Fangzhou has signed a MoU with Novo Nordisk to collaborate on the management of serious chronic diseases, including obesity and diabetes.

Lawmakers are trying to restore access to GLP-1 weight loss drugs, like Ozempic and Wegovy, after Ohio removed medical ...

A WOMAN who’s shed nearly 25% of her bodyweight thanks to Mounjaro has revealed which foods she steered clear of. TikToker ...

Fitness experts say using weight-loss drugs is just one piece of the puzzle for many attempting to live healthier ...

As the global obesity medication market skyrockets, South Korean pharmaceuticals are rushing to develop national obesity ...

Pre-diabetes now affects as many as one-third of children ages 12-17. As a physician this is why Ozempic should still not be ...

Novo Nordisk A/S (NYSE: NVO) is one of the high-margin pharma stocks to buy now. Berenberg has reaffirmed its Hold rating on ...

It turns out that obesity may be much more complicated than we thought, with the condition potentially existing in up to 11 ...

From legal pitfalls to temperature-sensitive drugs, here’s how to travel safely and legally with your medication ...

Novo Nordisk NVO generates most of its revenues from the sales of its blockbuster GLP-1 injections, Ozempic for type II ...

On April 29, 2025, Hims & Hers and Novo Nordisk unveiled a landmark collaboration to bring Wegovy—Novo's blockbuster ...

You can bring needles and injectable medicines like EpiPens (for allergies), insulin or Wegovy in your hand luggage. But it’s important to carry a doctor’s note stating your medical condition and the ...